Press enter to search Â
We found 1 results.
However, the instrument segment is expected to register the highest CAGR in the human leukocyte antigen (HLA) testing market during 2022–2028. Jan-2020 Thermo Fisher Scientific plans to acquire point-of-care molecular diagnostics firm Mesa Biotech for up to $550 million, the company said on Tuesday. Aug-2021 BioReference Laboratories announced that it has acquired the Ariosa centralized prenatal testing business from Roche. Feb-2022 Takara Bio has announced that they will be opening an expansion of its manufacturing facility, the center for Gene and Cell Processing (CGCP), at the company's headquarters in Shiga, Japan. Jan-2021 Omixon announce that their flagship Holotype HLA assay and software solution as well as Monotype HLA configuration for disease association studies for HLA typing by Next Generation Sequencing (NGS) has been selected as the HLA typing solution of choice by the Establishment Francais du Sang ( the French National Blood Service, EFS).
0
However, the instrument segment is expected to register the highest CAGR in the human leukocyte antigen (HLA) testing market during 2022–2028. Jan-2020 Thermo Fisher Scientific plans to acquire point-of-care molecular diagnostics firm Mesa Biotech for up to $550 million, the company said on Tuesday. Aug-2021 BioReference Laboratories announced that it has acquired the Ariosa centralized prenatal testing business from Roche. Feb-2022 Takara Bio has announced that they will be opening an expansion of its manufacturing facility, the center for Gene and Cell Processing (CGCP), at the company's headquarters in Shiga, Japan. Jan-2021 Omixon announce that their flagship Holotype HLA assay and software solution as well as Monotype HLA configuration for disease association studies for HLA typing by Next Generation Sequencing (NGS) has been selected as the HLA typing solution of choice by the Establishment Francais du Sang ( the French National Blood Service, EFS).